| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Environmental Sciences and Engineering [S. M. O., J. A. S.], and Pathology [J. A. S.], University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, and Departments of Cellular and Molecular Physiology and of Pharmacology, Pennsylvania State University College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033 [A. E. P.]
Concentrations of O6-methylguanine, O4-methylthymidine, and N-7-methylguanine were measured in the livers of Fischer 344 rats following treatment with 1,2-dimethylhydrazine (20 mg/kg, s.c.) alone or in combination with the O6-alkylguanine transferase inhibitor O6-benzylguanine (100 mg/kg, i.p., daily). Animals were sacrificed at 12, 24, 36, or 48 h following 1,2-dimethylhydrazine exposure. Direct measurement of alkyltransferase demonstrated that daily treatment with O6-benzylguanine completely eliminated detectable alkyltransferase activity in the livers of treated rats. Adducts in liver DNA were quantitated by high performance liquid chromatography separation followed by fluorescence detection, UV absorbance, and/or specific radioimmunological assays. In animals exposed to 1,2-dimethylhydrazine alone O6-methylguanine concentrations declined rapidly, whereas animals exposed to both O6-benzylguanine and 1,2-dimethylhydrazine showed less removal of O6-methylguanine, with significant differences between the two populations appearing at 36 and 48 h. O4-Methylthymidine removal also differed significantly between the two groups, with O6-benzylguanine-treated animals exhibiting higher concentrations of adducts at 36 and 48 h. O6-Benzylguanine treatment had no effect on the removal of N-7-methylguanine. These results show that the rate of disappearance of both O6-methylguanine and O4-methylthymidine is slower following alkyltransferase depletion, suggesting that mammalian alkyltransferase is involved in the removal of O4-methylthymidine lesions as well as O6-methylguanine lesions.
1 To whom requests for reprints should be addressed, at Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Campus Box 7400, Chapel Hill, NC 27599.
Received 2/15/93. Accepted 6/22/93.
This article has been cited by other articles:
![]() |
O. S. Sohn, E. S. Fiala, S. P. Requeijo, J. H. Weisburger, and F. J. Gonzalez Differential Effects of CYP2E1 Status on the Metabolic Activation of the Colon Carcinogens Azoxymethane and Methylazoxymethanol Cancer Res., December 1, 2001; 61(23): 8435 - 8440. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Peterson, N. M. Thomson, D. L. Crankshaw, E. E. Donaldson, and P. J. Kenney Interactions between Methylating and Pyridyloxobutylating Agents in A/J Mouse Lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis Cancer Res., August 1, 2001; 61(15): 5757 - 5763. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Encell and L. A. Loeb Enhanced in vivo repair of O4-methylthymine by a mutant human DNA alkyltransferase Carcinogenesis, July 1, 2000; 21(7): 1397 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Mancini, E. R. Glaze, P. L. Stetson, and H. S. Greenberg Sensitization of 1,3-bis(2-Chloroethyl)-1-nitrosourea and Cisplatin Cytotoxicity by 5-Bromo-2'-deoxyuridine in Human Glioma J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1404 - 1409. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |